Thymalin
A peptide blend extracted from the thymus glands of young animals. The thymus is the gland that helps train your immune cells. This preparation supports thymus activity and helps your body mature T-cells — the immune cells that fight infections and cancer. It's been used in Russian medicine for decades, though Western clinical evidence is still limited.
Dosage
10 mg intramuscular daily for 5-10 days, 1-2x yearly
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Get Research-Grade Thymalin
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Immune Restoration
Thymic peptide complex restores T-cell maturation and CD4/CD8 balance.
NK Cell Enhancement
Improves natural killer cell cytotoxic activity for immune surveillance.
Mechanism of Action
Thymalin is a complex of short peptides extracted from bovine thymus glands, representing the biologically active fraction of thymic hormones. The thymus gland is the primary organ of T-cell maturation — bone marrow-derived T-cell precursors migrate to the thymus where they undergo positive and negative selection, emerging as mature, immunocompetent CD4+ helper and CD8+ cytotoxic T cells. The thymus produces a suite of peptide hormones that guide this maturation process, and Thymalin contains a mixture of these bioactive peptides.
The peptide complex acts at multiple points in the immune system. It promotes the differentiation of pre-T cells into mature T-cell subsets, restoring the CD4/CD8 ratio toward normal values (typically 1.5-2.5:1 in healthy individuals). It enhances natural killer (NK) cell cytotoxic activity, which is critical for immune surveillance against virus-infected and neoplastic cells. It modulates cytokine production — generally promoting a balanced Th1/Th2 response rather than driving either extreme — and enhances macrophage phagocytic capacity.
The relevance to aging is direct: the thymus undergoes progressive involution (shrinkage) beginning at puberty, and by age 60-70, most thymic tissue has been replaced by fat, with minimal residual T-cell educating capacity. This thymic involution is a major driver of immunosenescence — the age-related decline in immune function that increases susceptibility to infections, cancers, and autoimmune conditions while reducing vaccine responsiveness. Thymalin aims to pharmacologically replace the thymic peptide signals lost through involution, partially restoring the immune system's ability to produce new, functional T cells. Research from the Khavinson group has reported that Thymalin treatment in elderly patients was associated with reduced mortality and improved immune markers over long-term follow-up, though these studies require independent replication in Western clinical settings.
Regulatory Status
Approved in Russia for immune deficiency states. Not FDA approved. Limited Western clinical data. Available through specialty peptide suppliers.
Risks & Safety
Common
pain and reactions at the injection site, mild fatigue during the first course.
Serious
limited Western clinical data, most evidence comes from Russian institutions.
Rare
severe allergic reaction, may trigger autoimmune activity in predisposed individuals.
Compare Thymalin With
Research Papers
3Published: August 28, 2023
AI Summary
Thymalin's active components KE and EW reduced inflammatory cytokines IL-1β, IL-6, and TNF-α by 1.4 to 6 times in immune cells. The immunomodulatory effect in COVID-19 appears to involve regulating proteins linked to the cytokine storm.
Published: March 24, 2022
AI Summary
Thymalin was one of five Khavinson peptides that modulated inflammatory pathways in monocytes and macrophages. All five reduced TNF and IL-6 production and cell adhesion, acting as anti-inflammatory molecules.
Published: February 10, 2021
AI Summary
Adding thymalin to standard COVID-19 therapy accelerated the decline in IL-6, C-reactive protein, and D-dimer, and improved T-cell markers. The peptide also helped reduce the risk of blood clots.
Frequently Asked Questions
What is Thymalin?
A peptide blend extracted from the thymus glands of young animals. The thymus is the gland that helps train your immune cells. This preparation supports thymus activity and helps your body mature T-cells — the immune cells that fight infections and cancer. It's been used in Russian medicine for decades, though Western clinical evidence is still limited.
What is Thymalin used for?
A peptide blend extracted from the thymus glands of young animals. The thymus is the gland that helps train your immune cells. This preparation supports thymus activity and helps your body mature T-cells — the immune cells that fight infections and cancer. It's been used in Russian medicine for decades, though Western clinical evidence is still limited.
What is the dosage for Thymalin?
Standard: 10 mg intramuscular once daily for 5-10 days. Cycled once or twice yearly for immune support. Some protocols use 10-day courses at the start of cold/flu season.
What are the side effects of Thymalin?
Common: pain and reactions at the injection site, mild fatigue during the first course. Serious: limited Western clinical data, most evidence comes from Russian institutions. Rare: severe allergic reaction, may trigger autoimmune activity in predisposed individuals.
How does Thymalin work?
Thymalin is a complex of short peptides extracted from bovine thymus glands, representing the biologically active fraction of thymic hormones. The thymus gland is the primary organ of T-cell maturation — bone marrow-derived T-cell precursors migrate to the thymus where they undergo positive and negative selection, emerging as mature, immunocompetent CD4+ helper and CD8+ cytotoxic T cells. The thymus produces a suite of peptide hormones that guide this maturation process, and Thymalin contains a mixture of these bioactive peptides. The peptide complex acts at multiple points in the immune system. It promotes the differentiation of pre-T cells into mature T-cell subsets, restoring the CD4/CD8 ratio toward normal values (typically 1.5-2.5:1 in healthy individuals). It enhances natural killer (NK) cell cytotoxic activity, which is critical for immune surveillance against virus-infected and neoplastic cells. It modulates cytokine production — generally promoting a balanced Th1/Th2 response rather than driving either extreme — and enhances macrophage phagocytic capacity. The relevance to aging is direct: the thymus undergoes progressive involution (shrinkage) beginning at puberty, and by age 60-70, most thymic tissue has been replaced by fat, with minimal residual T-cell educating capacity. This thymic involution is a major driver of immunosenescence — the age-related decline in immune function that increases susceptibility to infections, cancers, and autoimmune conditions while reducing vaccine responsiveness. Thymalin aims to pharmacologically replace the thymic peptide signals lost through involution, partially restoring the immune system's ability to produce new, functional T cells. Research from the Khavinson group has reported that Thymalin treatment in elderly patients was associated with reduced mortality and improved immune markers over long-term follow-up, though these studies require independent replication in Western clinical settings.
How is Thymalin administered?
Thymalin is administered via intramuscular injection.
What is the half-life of Thymalin?
The half-life of Thymalin is Variable (complex peptide mixture; estimated several hours).
Is Thymalin legal?
Approved in Russia for immune deficiency states. Not FDA approved. Limited Western clinical data. Available through specialty peptide suppliers.
Related Peptides
AEDG Peptide
A tetrapeptide (Ala-Glu-Asp-Gly) identical to Epithalon's core active sequence — effectively the same compound. Studied for telomerase activation and pineal gland regulation, promoting melatonin production and potentially slowing cellular aging through telomere maintenance. Part of the Khavinson bioregulator peptide family developed in St. Petersburg.
CJC-1295 (no DAC)
One of the most popular growth hormone peptides, often called Mod GRF 1-29. Instead of injecting growth hormone directly, this tells your pituitary gland to release more of its own GH naturally. This is considered healthier than injecting GH directly because your body keeps its normal feedback systems intact. Usually combined with Ipamorelin for much stronger effects — the two work together better than either alone.
CJC-1295 + Ipamorelin
The most commonly prescribed peptide combination in anti-aging and regenerative medicine. Pairs the GHRH analogue CJC-1295 (Mod GRF 1-29) with the selective ghrelin-mimetic Ipamorelin for synergistic, pulsatile growth hormone release. Exploits two complementary signaling pathways — cAMP (GHRH) and calcium/PLC (ghrelin receptor) — to amplify GH pulses while maintaining minimal side effects.
CJC-1295 with DAC
The long-acting version of CJC-1295. After injection it attaches to a protein in your blood (albumin), which keeps it active for nearly a week instead of just 30 minutes. This means you only need to inject once a week. The trade-off is that it keeps growth hormone elevated constantly rather than in natural pulses, which some practitioners consider less ideal for your body. More convenient but potentially less natural than the no-DAC version.